Sanofi ADR

Sanofi ADR

Yahoo Finance • 2 days ago

Retension Pharmaceuticals prices upsized IPO at $12 per share

[IPO Concept with Stock Market Graphs] AlexSecret * Retension Pharmaceuticals (RTSN [https://seekingalpha.com/symbol/RTSN]) priced its upsized IPO at $12 per share. * The clinical-stage biopharmaceutical company developing treatments... Full story

Yahoo Finance • 2 days ago

Veeva Summit to Showcase AI Innovations and the Leaders Transforming R&D and Quality

Eli Lilly and Company, Pfizer, Sanofi, UCB, and more share learnings speeding drug development, connecting trials, and modernizing quality and manufacturing PLEASANTON, Calif., Oct. 8, 2026 /PRNewswire/ -- At Veeva R&D and Quality Summit... Full story

Yahoo Finance • 5 days ago

Housekeeping Starts with Branding: Vicapsys Life Sciences Adopts New Corporate Identity Developed by FutureBrand for Vicapsys and Its Stateline Subsidiary

FutureBrand Hispanic America onboards Vicapsys and delivers a unified visual identity for Vicapsys Life Sciences and its Stateline subsidiary Two linked brands under one visual system: Vicapsys as the umbrella brand and Stateline as the op... Full story

Yahoo Finance • 8 days ago

Sanofi and 2026 NBA Champion Karl-Anthony Towns team up to raise awareness of COVID-19 vaccination with NUVAXOVID®

The six-time NBA All-Star, three-time All-NBA selection, 2016 NBA Rookie of the Year, and 2026 NBA Champion Karl-Anthony Towns brings his personal experience with COVID-19 to encourage eligible people, especially those at increased risk, t... Full story

Yahoo Finance • 8 days ago

European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading

European equities traded in the US as American depositary receipts were trending higher late Friday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 10 days ago

Regeneron and Sanofi Expand Global Alliance with Multiple Next-Generation, Long-Acting Immunology Antibodies

Regeneron Pharmaceuticals, Inc. REGN20423, a clinical-stage long-acting IL-13 monoclonal antibody invented and developed by Regeneron, is added to the alliance, along with a long-acting IL-4xIL-13 bispecific and two other long-acting prec... Full story

Yahoo Finance • 10 days ago

Press Release: Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies

Sanofi Winthrop Industrie Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies REGN20423, a clinical-stage long-acting IL-13 monoclonal antibody invented and developed by Regeneron,... Full story

Yahoo Finance • 10 days ago

Pharmaceutical industry lobbying group names new CEO, Eric Cantor

[Cantor And John Thune Hold Press Conference On Economy] Alex Wong/Getty Images News * The Pharmaceutical Research and Manufacturers of America (PhRMA) has selected former Republican House Majority Leader Eric Cantor as its next CEO and... Full story

Yahoo Finance • 11 days ago

Amazon, Walmart Surplus Auctioneer Climbs Toward A Breakout; Stock Up 45%

The liquidation auctioneer Liquidity Services is closing in on a buy point. The stock is up roughly 45% this year. Continue Reading... Full story

Yahoo Finance • 17 days ago

European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading

European equities traded in the US as American depositary receipts were tracking lower Wednesday mor PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 18 days ago

MRNA Hits 52-Week High: How Melanoma Study Results Keep Rally Going

Shares of Moderna MRNA rose 12% yesterday, even climbing to a new 52-week high of $176.86. The rally came as investors digested the company's announcement that it will present detailed data from the phase III INTerpath-001 study on intisme... Full story

Yahoo Finance • 19 days ago

Capitalize on the Orphan Drug Revenue Shift: Benchmark Novartis, Roche, Pfizer, Sanofi and AstraZeneca to Secure High-Value Growth Before Rivals Move First

Company Logo Orphan drug demand is rising as genomics, biologics and personalized therapies advance, aided by faster approvals, government incentives, advocacy and improved rare-disease diagnosis. Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE)... Full story

Yahoo Finance • 23 days ago

Is CRBP a Good Cannabis Investment After Positive Obesity Study Data?

Corbus Pharmaceuticals CRBP has emerged as an unusual way for investors to gain exposure to the cannabis space. The company recently announced positive results from an early-stage study on its obesity candidate CRB-913, an oral cannabinoid... Full story

Yahoo Finance • 24 days ago

Tarja Stenvall Appointed Chief Executive Officer of Bavarian Nordic

Bavarian Nordic A/S COPENHAGEN, Denmark, September 17, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that Tarja Stenvall has been appointed President and Chief Executive Officer, effective October 15, 2026, succeeding Paul Chapli... Full story

Yahoo Finance • 24 days ago

Sector Update: Healthcare Stocks Edge Lower Late Afternoon

Healthcare stocks were slightly lower late Wednesday afternoon, with the NYSE Healthcare Index fract PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 24 days ago

HHS to launch autism research initiative utilizing AI: report

[A cardboard sign with the diagnosis of autism made of multicolored letters in the hands of a child on a purple background with pieces of colorful puzzles.] Maryna Auramchuk/iStock via Getty Images * HHS is expected to unveil an autism... Full story

Yahoo Finance • 25 days ago

Novo Nordisk vs. Regeneron Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?

The race for pharmaceutical dominance often centers on chronic disease management. For investors, deciding between Novo Nordisk (NYSE:NVO) and Regeneron Pharmaceuticals (NASDAQ:REGN) requires a close look at their unique market strengths.... Full story

Yahoo Finance • 25 days ago

Cheplapharm to take over 20 medicines and three sites from Sanofi

Cheplapharm has entered a strategic partnership to take over a portfolio of 20 mature medicines, along with three manufacturing facilities globally, from Sanofi. Under the proposed arrangement, Sanofi will receive a 26.4% equity stake in... Full story

Yahoo Finance • 26 days ago

Hummingbird Bioscience Appoints Dr. James Garner as President

Hummingbird Bioscience Experienced life sciences executive brings more than two decades of global drug development, commercialization and business development experience SINGAPORE, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Hummingbird Bioscienc... Full story

Yahoo Finance • 26 days ago

Sector Update: Healthcare Stocks Rise in Afternoon Trading

Healthcare stocks advanced Monday afternoon, with the NYSE Healthcare Index up 1.6% and the State St PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story